Bristol Is Not Bayer: Primary Care Strategy Is “Different, Not Exit”

Bristol-Myers Squibb is trying a "different model" for primary care, but the company has no intention of exiting the market, CEO Peter Dolan told the Bear Stearns conference in New York Sept. 13